| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 304,688 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 92,560 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 255,750 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 125,001 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 113,920 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 40,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 25,800 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 20,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 37,500 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 85,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 75,000 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 33,750 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 52,600 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 71,700 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 33,800 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 29,611 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jun 11 | D | 47,354 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Jun 11 | D | 479,989 | $0.00 | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | May 21 | M | 23,250 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 22 | S | 10,926 | $26.78 | $293K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 21 | M | 23,250 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | May 17 | M | 2,419 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 18 | S | 1,129 | $26.76 | $30K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 17 | M | 2,419 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | May 11 | M | 7,120 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 12 | S | 3,322 | $26.71 | $89K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | May 11 | M | 7,120 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Apr 16 | M | 20,312 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Apr 17 | S | 9,550 | $20.22 | $193K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Apr 16 | M | 20,312 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Mar 6 | M | 15,625 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Mar 9 | S | 6,693 | $16.08 | $108K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Mar 6 | M | 15,625 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Feb 21 | M | 23,250 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 23 | S | 10,034 | $15.57 | $156K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 21 | M | 23,250 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Feb 17 | M | 2,419 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 18 | S | 1,038 | $15.00 | $16K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 17 | M | 2,419 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Feb 11 | M | 7,120 | $0.00 | —? |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 12 | S | 3,354 | $15.70 | $53K |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEO | Feb 11 | M | 7,120 | — | — |
| KalVista Pharmaceuticals, Inc. | KALV | Benjamin L. PalleikoCEODERIV | Jan 16 | A | 325,000 | $0.00 | —? |